La cooperación tecnológica entre bibliotecas digitales académicas de México
- 期刊名称Investigación Bibliotecológica: Archivonomía, Bibliotecología e Información
- 作者Torres Vargas, Georgina Araceli
- 卷第28卷
- 期第62期
- 印刷ISSN0187-358X
- 文件大小299.69KB
- 发表时间2014-01
- DOI10.1016/s0187-358x(14)72566-3
- 页码67-79
Improved survival of patients with chronic myelogenous leukemia undergoing allogeneic bone marrow transplantationJan Moreb; Thomas Johnson; Paul Kubilis; Lesley Myers; David Oblon; Alan Miller; Gerald Elfenbein; Roy Weiner · 1995
Effects of vitamin a on survival in patients with chronic myelogenous leukemia: A SWOG randomized trialFrank L. Meyskens Jr; Kenneth J. Kopecky; Frederick R. Appelbaum; Stanley P. Balcerzak; Wolfram Samlowski; Harry Hynes · 1995
Prolonged Survival (17 Years) in a Patient with Chronic Myelogenous Leukemia after Therapy for Hodgkin's DiseaseSalvagno, Luigi; Sorarú, Mariella; Leszl, Anna; Koussis, Haralabos; Franchise, Giuseppe De; Fiorentino, Mario V. · Leukemia & Lymphoma · 1994
Biological Determinants of Long-Term Survival in Chronic Myelogenous Leukemia Patients Treated with Conventional ChemotherapyFoa, Paolo; Iurlo, Alessandra; Orazi, Attilio; Saglio, Giuseppe; Ribera, Sonia; Bertoni, Francesco; Caldiera, Sarah; Fornier, Monica; Maiolo, Anna Teresa · Acta Haematologica · 1997
Chronic myelogenous leukemia: a multivariate analysis of the associations of patient characteristics and therapy with survivalKantarjian, HM; Smith, TL; McCredie, KB; Keating, MJ; Walters, RS; Talpaz, M; Hester, JP; Bligham, G; Gehan, E; Freireich, EJ · Blood · 1985
Survival advantage from imatinib compared with the combination interferon- plus cytarabine in chronic-phase chronic myelogenous leukemia: historical comparison between two phase 3 trialsRoy, L. · Blood · 2006
Survival with Chronic Myelogenous Leukemia: The Outcome of a Patient Who HadOne of the Longest SurvivalsÖzet, Ahmet; Özet, Gülsüm; Çalışkaner, Zafer; Kömürcü, Şeref; Arpacı, Fikret; Berk, Önder · Oncology · 1998
Paratesticular rhabdomyosarcoma in adult patients: 16-year experience at Institut Gustave-Roussy.Kattan, J; Culine, S; Terrier-Lacombe, M J; Theodore, C; Droz, J P · Annals of oncology : official journal of the European Society for Medical Oncology / ESMO · 1993
Second-line platinum therapy in patients with ovarian cancer previously treated with cisplatin.Markman, M; Rothman, R; Hakes, T; Reichman, B; Hoskins, W; Rubin, S; Jones, W; Almadrones, L; Lewis, J L · Journal of clinical oncology : official journal of the American Society of Clinical Oncology · 1991
Intrathecal chemotherapy for treatment of overt meningeal leukemia: comparison between intraventricular and traditional intralumbar routeIacoangeli, M; Roselli, R; Pagano, L; Leone, G; Marra, R; Pompucci, a; Trignani, R; Scerrati, M · Annals of oncology: official journal of the European Society for Medical Oncology / ESMO · 1995
Vascular toxicity and the mechanism underlying Raynaud's phenomenon in patients treated with cisplatin, vinblastine and bleomycin.Hansen, S W; Olsen, N; Rossing, N; Rorth, M · Annals of oncology : official journal of the European Society for Medical Oncology / ESMO · 1990
A phase I trial of continuous infusion interleukin-4 (IL-4) alone and following interleukin-2 (IL-2) in cancer patients.Sosman, J a; Fisher, S G; Kefer, C; Fisher, R I; Ellis, T M · Annals of oncology : official journal of the European Society for Medical Oncology / ESMO · 1994
The effects of morphine on dyspnea and ventilatory function in elderly patients with advanced cancer: a randomized double-blind controlled trial.Mazzocato, C; Buclin, T; Rapin, C H · Annals of oncology : official journal of the European Society for Medical Oncology / ESMO · 1999
Randomized phase III study of temozolomide versus dacarbazine in the treatment of patients with advanced metastatic malignant melanoma.Middleton, M R; Grob, J J; Aaronson, N; Fierlbeck, G; Tilgen, W; Seiter, S; Gore, M; Aamdal, S; Cebon, J; Coates, a; Dreno, B; Henz, M; Schadendorf, D; Kapp, a; Weiss, J; Fraass, U; Statkevich, P; Muller, M; Thatcher, N · Journal of clinical oncology : official journal of the American Society of Clinical Oncology · 2000
Docetaxel (Taxotere): an active drug for the treatment of patients with advanced squamous cell carcinoma of the head and neck. EORTC Early Clinical Trials Group.Catimel, G; Verweij, J; Mattijssen, V; Hanauske, a; Piccart, M; Wanders, J; Franklin, H; {Le Bail}, N; Clavel, M; Kaye, S B · Annals of oncology : official journal of the European Society for Medical Oncology / ESMO · 1994